Trials / Completed
CompletedNCT00465192
Efficacy and Safety of 17-Beta Estradiol in Treatment of Atrophic Vaginitis
A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Multicenter Study Comparing the Efficacy and Safety of 17-Beta Estradiol 10 Micrograms and 25 Micrograms (Vagifem) Doses in Treatment of Estrogen Deficiency-Derived Atrophic Vaginitis
- Status
- Completed
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- 230 (estimated)
- Sponsor
- Novo Nordisk A/S · Industry
- Sex
- Female
- Age
- 45 Years – 80 Years
- Healthy volunteers
- Not accepted
Summary
This trial was conducted in the United States of America (USA). This trial aimed for a comparison between the effect of two different doses of estradiol on parameters related to efficacy and safety.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | estradiol, 10 mcg | |
| DRUG | estradiol, 25 mcg | |
| DRUG | placebo |
Timeline
- Start date
- 1994-08-31
- Primary completion
- 1995-11-30
- Completion
- 1995-11-30
- First posted
- 2007-04-24
- Last updated
- 2017-03-01
Source: ClinicalTrials.gov record NCT00465192. Inclusion in this directory is not an endorsement.